Cortec (CRTQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cortec (CRTQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bobby Yellin who wrote (10)	12/7/1996 10:32:00 PM
From: AgAuUSA	of 22

Bobby, Price looks right. One product upheld in trials pending redo on a rat issue where deaths occurred. Other studies are progressing normally. Re: rat study deaths: was preclinical study...and may have involved errors by a technician in preparing the compound; NO human clinical encountered problems. Further, all work and funding is being done by SKB...so they have a vested interest in working things out. Bottom line...I've been buying. Cash level and other studies make risk/reward very investor favorable, IMHO. Also, failure of the halted trial product is fully factored into the stock price, IMHO. Use DD. All opinions are IMHO. I own the stock so I may be biased. Best, Greg

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next